We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Boeing (BA) Wins $280M Deal to Support SDBI Weapon System
Read MoreHide Full Article
The Boeing Company’s (BA - Free Report) Defense, Space, and Security unit (BDS) recently secured a $280-million deal to provide engineering support to the Small Diameter Bomb (SDB) I weapon system. The contract was awarded by the Air Force Life Cycle Management Center, Eglin Air Force Base, FL.
Per the terms, the BDS unit will provide SDB weapon integration on selected weapon platforms and support the fielded weapon system. Work related to the deal will be performed in St. Louis, MO, and is scheduled to be completed by September 2024.
SDB’S Growing Importance Among Global Militaries
With increased cross-border tensions across the globe, both developed and developing countries have been ramping up their defense arsenal over the past decade. Notably, bombs and other major munitions comprise a significant part of the weapon portfolio.
To this end, munitions like SDB’s have seen its importance grow over the years, as militaries of Australia, Belgium, Canada, Denmark, Greece, Israel, South Korea, the Netherlands, Spain, Sweden, Turkey and Singapore have opted for these bombs as one of their preferred choice of munition. Such global acceptance of these bombs significantly benefits its makers like Boeing and Raytheon .
Global Prospects of the Munitions Market
Per Grand View Research, the global munitions market is expected to see a CAGR of 3.5% by 2024 to reach $16 billion. Such growth can be attributed to the rise in terrorism accompanied by continuous stacking of arms and weapons in emerging economies, owing to rising defense expenditures. Such projections, on a whole, should enable Boeing to significantly grow in the expanding global munitions market in the days ahead.
Our View
Boeing’s SDB is one of the very few weapon systems of its kind in the global munitions market. Being one of the largest defense contractors in the United States, Boeing serves the U.S. aerospace and defense industry and its allies by producing, integrating and supporting precise, long-range and focused munition capabilities. Currently, the demand for SDB is high, given the fact that apart from the United States, eight foreign allies of the country use this precision weapon.
With more nations bumping up their defense spending, Boeing consistently enjoys frequent order flow from international markets for advanced weapons like SDB. The latest contract win is a further testament to that.
Furthermore, the fiscal 2020 defense budget reflects a solid spending provision of $5.1 billion for munitions. Such allocations should usher in more contracts for renowned munition manufacturers like Boeing.
Price Performance
In the past month, Boein's stock has gained 7.5% compared with the industry’s 5% growth.
Lockheed Martin came up with average positive earnings surprise of 16.03% in the last four quarters. The Zacks Consensus Estimate for 2019 earnings has increased 3.31% to $21.20 in the past 60 days.
Heico came up with average positive earnings surprise of 1.19% in the last four quarters. The Zacks Consensus Estimate for 2019 earnings has risen 4.1% to $2.30 over the past 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Boeing (BA) Wins $280M Deal to Support SDBI Weapon System
The Boeing Company’s (BA - Free Report) Defense, Space, and Security unit (BDS) recently secured a $280-million deal to provide engineering support to the Small Diameter Bomb (SDB) I weapon system. The contract was awarded by
the Air Force Life Cycle Management Center, Eglin Air Force Base, FL.
Per the terms, the BDS unit will provide SDB weapon integration on selected weapon platforms and support the fielded weapon system. Work related to the deal will be performed in St. Louis, MO, and is scheduled to be completed by September 2024.
SDB’S Growing Importance Among Global Militaries
With increased cross-border tensions across the globe, both developed and developing countries have been ramping up their defense arsenal over the past decade. Notably, bombs and other major munitions comprise a significant part of the weapon portfolio.
To this end, munitions like SDB’s have seen its importance grow over the years, as militaries of Australia, Belgium, Canada, Denmark, Greece, Israel, South Korea, the Netherlands, Spain, Sweden, Turkey and Singapore have opted for these bombs as one of their preferred choice of munition. Such global acceptance of these bombs significantly benefits its makers like Boeing and Raytheon .
Global Prospects of the Munitions Market
Per Grand View Research, the global munitions market is expected to see a CAGR of 3.5% by 2024 to reach $16 billion. Such growth can be attributed to the rise in terrorism accompanied by continuous stacking of arms and weapons in emerging economies, owing to rising defense expenditures. Such projections, on a whole, should enable Boeing to significantly grow in the expanding global munitions market in the days ahead.
Our View
Boeing’s SDB is one of the very few weapon systems of its kind in the global munitions market. Being one of the largest defense contractors in the United States, Boeing serves the U.S. aerospace and defense industry and its allies by producing, integrating and supporting precise, long-range and focused munition capabilities. Currently, the demand for SDB is high, given the fact that apart from the United States, eight foreign allies of the country use this precision weapon.
With more nations bumping up their defense spending, Boeing consistently enjoys frequent order flow from international markets for advanced weapons like SDB. The latest contract win is a further testament to that.
Furthermore, the fiscal 2020 defense budget reflects a solid spending provision of $5.1 billion for munitions. Such allocations should usher in more contracts for renowned munition manufacturers like Boeing.
Price Performance
In the past month, Boein's stock has gained 7.5% compared with the industry’s 5% growth.
Zacks Rank & Key Picks
Boeing currently carries a Zacks Rank #3 (Hold).
A few better-ranked stocks in the same sector are Lockheed Martin Corporation (LMT - Free Report) and Heico Corporation (HEI - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Lockheed Martin came up with average positive earnings surprise of 16.03% in the last four quarters. The Zacks Consensus Estimate for 2019 earnings has increased 3.31% to $21.20 in the past 60 days.
Heico came up with average positive earnings surprise of 1.19% in the last four quarters. The Zacks Consensus Estimate for 2019 earnings has risen 4.1% to $2.30 over the past 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>